CONMED Corporation reported strong third-quarter results, with double-digit revenue and earnings growth. The company has updated its full-year revenue guidance to between $1.240 billion and $1.260 billion and adjusted diluted net earnings per share to a range of $3.45 to $3.55.
The company experienced double-digit revenue and earnings growth.
Above-market revenue growth was achieved in both businesses.
Full-year revenue is expected to be between $1.240 billion and $1.260 billion.
Adjusted diluted net earnings per share are projected to be in the range of $3.45 to $3.55.
CONMED anticipates full-year revenue between $1.240 billion and $1.260 billion, and adjusted diluted net earnings per share in the range of $3.45 to $3.55.